Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (23530)	4/24/2007 10:15:55 AM
From: Robohogs	Read Replies (1) \| Respond to of 52153

I am running my own curves too and I noticed the compression and parity on put-call coming back into play. I speculated on someone knowing Teva or Ampha news - hard to tell. Would be illegal I think to trade MNTA on that news. Jon

To: Biomaven who wrote (23530)	4/24/2007 11:36:27 AM
From: IRWIN JAMES FRANKEL	Read Replies (1) \| Respond to of 52153

>>One speculative idea for a near-term news event (suggested to me by rkrw) is that Teva or Amphostar has received news (or hints) from the FDA on their applications. A very interesting legal question is whether it would be permissible for anyone from those companies to trade MNTA based on such news. To say a TEVA insider could not trade MNTA because of the implications to MNTA of information he found out about a TEVA product is a stretch. It seems to me that the reason for the rule is to prevent insiders who owe a fiduciary duty to the company from appropriating the benefit to themselves and thus disadvantaging the stockholders. But it is a very interesting question. I had commented on this on the MNTA thread: Message 23466755